Top five articles of the week from Specialty Pharmacy Times.
5. FDA Approves Expanded Use for Regorafinib to Treat Liver Cancer
Stivarga is the first FDA-approved treatment for hepatocellular carcinoma in almost a decade.https://www.specialtypharmacytimes.com/news/fda-approves-expanded-use-for-regorafinib-to-treat-liver-cancer
4. How Do Manufacturer Rebates Impact Drug Prices?
Study finds drug prices have been both increasing and decreasing for prescription drugs, independent of rebates.https://www.specialtypharmacytimes.com/news/how-do-manufacturer-rebates-impact-drug-prices3. Health Reform: How is Pharma Affected?
Various health reform approaches may affect each pharmaceutical manufacturer differently.https://www.specialtypharmacytimes.com/news/health-reform-how-is-pharma-affected
2. Expedited Specialty Drug Approvals From Multiple Points of View
While the job of the FDA is to protect the public from ineffective drugs, patients in need of life-saving treatments push for accelerated approval of specialty drugs.https://www.specialtypharmacytimes.com/news/expedited-specialty-drug-approvals-from-multiple-points-of-view
1. Specialty Pharmacies Must be Value-Driven, Patient-Centric to Remain Competitive
Pharmacists and pharmacies have become key players in improving patient outcomes.https://www.specialtypharmacytimes.com/news/specialty-pharmacies-must-be-value-driven-patient-centric-to-remain-competitive